Information  X 
Enter a valid email address

Cambridge Cognition (COG)

  Print      Mail a friend       Annual reports

Thursday 31 October, 2019

Cambridge Cognition

Grant of Options

RNS Number : 8708R
Cambridge Cognition Holdings PLC
31 October 2019
 

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

 

Grant of Options

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces that on 30 October 2019, the Company granted options ("Options") over a total of 755,215 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's EMI option scheme (the "Grant").

Of these Options:

-     750,715 were granted to Persons Discharging Managerial Responsibilities ("PDMRs") on behalf of the Company, as follows:

Name

Role

Number of Options granted

Total number of options held following the Grant

Total number of Ordinary Shares held

Percentage of the current issued share capital held

Matthew Stork

Chief Executive Officer

392,858

392,858

50,000

0.21%

Ricky Dolphin

Chief Technology Officer

98,213

172,113

-

-

Jennifer Barnett

Chief Scientific Officer

90,000

141,500

7,213

0.03%

Malcolm Gates

Director of Group Finance

89,287

140,787

-

-

Fiona Cree

Global Head of Clinical Science

80,357

80,357

-

-

 

-     4,500 were granted to other employees of the Company.

All of the Options granted to PDMRs are exercisable at a price of 28 pence per Ordinary Share from three years following the date of award until the tenth anniversary of the date of award, subject to satisfying the following performance criteria:

-     50% of the Options granted will vest if the average closing mid-market price of an Ordinary Share for any three month period exceeds 100 pence, with the price on the last day of that period being at least 90 pence, and the last day of this period being no later than 30 September 2022; and

-     50% of the Options granted will vest if the average closing mid-market price of an Ordinary Share for any three month period exceeds 150 pence, with the price on the last day of that period being at least 135 pence, and the last day of this period being no later than 30 September 2022.

The remaining 4,500 Options awarded to other employees are exercisable at a price of 1 pence per Ordinary Share from two years following the date of award until the tenth anniversary of the date of award. All of these Options are granted over shares already in issue and held by Cambridge Cognition Trustees Limited on behalf of the Employee Benefit Trust.

Following the grant of Options, the total number of Options outstanding over unissued Ordinary Shares is 1,689,821, representing approximately 6.99% of the Company's issued share capital.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.           

Details of the person discharging managerial responsibilities / person closely associated

a)

Names

Matthew Stork    Chief Executive Officer

Ricky Dolphin     Chief Technology Officer

Jennifer Barnett Chief Scientific Officer

Malcolm Gates   Director of Group Finance

Fiona Cree         Global Head of Clinical Science

2.           

Reason for the Notification

a)

Position/status

See 1(a) above for positions - all classified as PDMRs of the Company

b)

Initial notification/ Amendment

Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cambridge Cognition Holdings Plc

b)

LEI

213800SZKDIN122EPA96

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

In each case, the grant of Options over Ordinary Shares on 30 October 2019

 

Identification code

GB00B8DV9647

b)

Nature of the transaction

Grant of Options over Ordinary Shares

 

c)

Price(s) and volume(s)

Price: n/a

Volumes:

Matthew Stork    392,858 options

Ricky Dolphin     98,213 options

Jennifer Barnett 90,000 options

Malcolm Gates   89,287 options

Fiona Cree         80,357 options

d)

Aggregated information:

·      Aggregated volume

·      Price

n/a

e)

Date of the transaction

30 October 2019

f)

Place of the transaction

Outside a trading venue

 

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014

Enquiries

Cambridge Cognition Holdings PLC


Matthew Stork, Chief Executive Officer

Nick Walters, Chief Financial Officer

Tel: 01223 810 700

[email protected]



finnCap Ltd (NOMAD and Joint Broker)

Tel: 020 7220 0500

Geoff Nash / Simon Hicks

(Corporate Finance)

Alice Lane/ Manasa Patil

(Corporate Broking)

 

Dowgate Capital Limited (Joint Broker)

David Poutney/ James Serjeant

Tel: 020 3903 7715

(Corporate Broking)



IFC Advisory Limited (Financial PR and IR)

Tel: 020 3934 6630

Tim Metcalfe/ Graham Herring/ Zach Cohen


 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHBLBDGSBXBGCB

a d v e r t i s e m e n t